Embed Size (px)
Citation preview
Innovations in pharmaceutical developmentEurope’s premier drug delivery and formulation event
Summit Brochurewww.ddfevent.com
12th Global
VIRTUAL15-17 March 2021
“One of the largest and best platforms to bring together large Pharma with
advanced CROs/CMOs as well as latest developments in Academia”
Stefan Bracht, Head of Disruptive Technology, Bayer
“Informative. Inspiring. Well organized. Felt spoiled (all those
breaks and lunches). To the point. Delivering as promised”
Iulia Oita, Stability Manager, Ablynx
“Cross active meeting, nice balance between Combination Product and Biologics, very engaging and very good case studies”
Kerstin Walke, Head Pharmaceutical Development, Boehringer Ingelheim
“Very interesting talks. The summit well organized. Amazing experience”
Giulio Cavalli, Process Scientist, Chiesi Ltd
“Lot of presentation with high quality, variety of topics, great chance for networking”
Hanna Kuśmierek, Site Manager, Janssen and Cilag
“Very good. Excellent breadth of presentations. Good representation
from both industry and academia”David Churchley, Pharmaceutical Development
Manager, ECO Animal Health
“Well organized, comfortable space, interesting sessions, good
networking opportunities”Mark Howansky, Associate Director, Device
Development, Bristol Myers Squibb
“Great range of high-quality speakers, comfortable venue and very well organised”David Harrison, Senior Alliance Lead, UCB Biopharma
What did the attendees think?
2
The perfect mix. The DDF Summit brings together leading formulation development and drug delivery scientists from both industry and academia to share and discuss their latest work.
Quality content. The agenda is packed with carefully selected talks on topics as diverse as the challenges you face.
Invaluable networking. The DDF community is open, friendly and represents and incredibly valuable network of scientists working at the forefront of their field. There is ample networking time built in to help you make and strengthen connections.
Tailor your experience. Four parallel streams give you the chance to personalise your agenda and delve deep into the topics pertinent to your challenges. Choose from Small Molecules, Biologics, Technology & Innovation or Device Development.
The right size. This year the DDF Summit will be limited to just 500 people, in order to maintain the quality of the networking and comfort for participants. This means that there will only be 250 delegate tickets available. So, don’t waste time in getting yours.
Key themes for 2021 include:• New modalities research opportunities and challenges • Personalised therapies, mRNA, Cell and gene therapies • Vaccine drying, stabilising and delivery • 3D printing, flexible manufacturing techniques, continuous manufacturing • mAb and bispecific formulation development • Oral delivery of biologics and other routes • Device development, microneedles, connected devices • Integrating human factors into device development, behavioural design
3
The virtual experienceBefore the show, you will be invited to create your profile and build your bespoke agenda.
PERSONALISED AGENDACreate your personalised agenda and receive reminders throughout the event. Book conference sessions, panel discussions or meetings with suppliers and view your planned activity all in one place.
LIVESTREAM CONTENTGlobal DDF Virtual includes 3 days of live and on-demand content. Hear expert speakers discuss vital developments and challenges live from anywhere in the world and participate via chats, polls and Q&As during each session.
NETWORK & ENGAGEShare your experiences in event group chats. Ask questions and discuss your needs with suppliers via direct messages. Discuss ideas with expert-speakers and the community in dedicated conference session chats.
CONNECTION MATCHMAKINGView a selection of AI-recommended “people you should meet”. Visit the profiles of suppliers and speakers that are of interest to you, send connection requests and book virtual one-to-one/group meetings.
VIRTUAL BOOTHSDiscover market-leading suppliers and visit their virtual booth to find out more or get in touch. Narrow your search with advanced filters such as region or product category to help find suppliers most relevant to you.
PRODUCT MARKETPLACEDiscover, compare and source products and services at the Global DDF Virtual product marketplace.
4
Stream Highlights:
Keynote Case Study Panel
Powder Characterization for Small Molecule Formulation – understanding the Particle-Powder-Processability InterfaceCarolin Auch, Principal Scientist | Lab Head Drug Delivery & Innovation, Merck
Challenges in the Pharmaceutical Development of Very Low Concentration Dosage Forms for Highly Potent Immunotherapy MoleculesNaila El Kechai, Formulation and Drug Product Team Leader, Sanofi
Vaccine Drying and High Throughput ScreeningErwan Bourles, Senior Manager, Head of Drying and Related Modelling Technologies Drug Product development Unit, GSK
Oral Delivery through Mixed MicellesGabriele Sadowski, Professor for Thermodynamics, TU Dortmond
Peptide Drug Delivery, Characterization and Product DevelopmentDr Ana L Gomes dos Santos, Principal Scientist, AstraZeneca
Click here for the full agenda
Biologics Small Molecules
Device Development
Technology & InnovationIn-Silico Excipient Screening for Pharmaceutical FormulationsGabriele Sadowski, Professor for Thermodynamics, TU Dortmond
Presentation by pmc isochempmc isochem
Impact of article 117 on the Development of New Combination ProductsDr. Fatima Bennai-Sanfourche, Director Medical device Safety, Medical Device Safety Officer, Bayer
Creating Digital Ecosystems that Improve OutcomesMatthew Clemente, Vice President, Device Development, Device R&D, Novo Nordisk
Material Properties of Amorphous Solid Dispersions – Influence of Incorporated DrugsKarsten Fluegel, Postdoctoral Researcher | Drug Delivery & Innovation, Merck
Nanotechnology Uses for Advanced Drug Delivery and TargetingOlivier Brass, Senior scientist, lead of research unit, research department, Sanofi
Pharmaceutical Process SimulationRobert Hennig, Associate Director Drug Delivery & Innovation, Healthcare R&D, Merck
Topic TBC: Novo NordiskRobert Hennig, Associate Director Drug Delivery & Innovation, Healthcare R&D, Merck
Keynote by Novo NordiskNovo Nordisk
Innovations in Ocular DeliveryKenneth J. Mandell, Founder and CEO, LayerBio
5
Claus-Michael LehrHead, Dept. of Drug Delivery (DDEL)Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS)
Serge MathonetGlobal Regulatory Affairs CMC Biologics – Site LeaderSanofi
Ahmad SheikhSenior Director, ACOS Senior Research FellowAbbVie
Philippe LeinardPre-Development Science LeaderSanofi
Sudhakar GaradDirectorNovartis
Helen Hao HouSenior Scientist Small Molecule Pharmaceutical SciencesGenentech
Bharathikumar Vellalore MaruthachalamPrinicipal ScientistJanssen
Fadee MondalekHead of internal developmentBayer
Rick PanicucciSenior Vice President CMCQED Therapeutics
Shwetha IyerSenior Scientist- Formulation and CharacterizationNovartis
Stefan BrachtHead of Disruptive TechnologiesBayer
Luis SantosScientistAstraZeneca
Andrea BenassiCMC – Chemistry Manufacturing & Controls - Drug Product Manufacturing & Innovation, New Technology & Innovation ScientistChiesi
Susan RosenbaumFounder, Chairman & Chief Executive OfficerLauren Sciences
Kenneth MandelCEOLayerbio
Dhairya MehtaHead, Connected & Software Medical DevicesTakeda
Kerstin WalkeVPBoehringer-Ingelheim
Naila El KechaiFormulation and Drug Product Team LeaderSanofi
Karsten FluegelPostdoctoral Researcher | Drug Delivery & InnovationMerck
Olivier BrassSenior scientist, lead of research unit, research departmentSanofi
Robert HennigAssociate Director Drug Delivery & Innovation, Healthcare R&DMerck
Speakers
Carolin AuchPrincipal Scientist | Lab Head Drug Delivery & InnovationMerck
Dr. Fatima Bennai-SanfourcheDirector Medical device Safety, Medical Device Safety OfficerBayer
Gabriele SadowskiProfessor for ThermodynamicsTU Dortmond
Matthew ClementeVice President, Device Development, Device R&DNovo Nordisk
Dr Ana L Gomes dos SantosPrincipal ScientistAstraZeneca
Ijeoma F. UchegbuChair in Pharmaceutical NanoscienceUniversity College London
Erwan BourlesSenior Manager, Head of Drying and Related Modelling Technologies Drug Product development UnitGSK
11th Global
6
V
Commercial PartnersIf you’re interested in becoming an official partner for the DDF Summit, please contact:
Alexandra Krcho [email protected] | +44 (0) 203 874 9205
Adare Pharmaceuticalswww.adarepharma.com
BASFwww.basf.com
BENEOwww.beneo.com
DelSiTechwww.delsitech.com
GOREwww.gore.com/pharmbio
Elkemsilicones.elkem.com
DFE Pharmawww.dfepharma.com
Foster Delivery Sciencewww.deliveryscience.com
Halo Labswww.halolabs.com
Lonza Pharma & Biotechpharma.lonza.com
Armor Pharmawww.armor-pharma.com
Catalentwww.catalent.com
7
Commercial Partners continued
Pionpion-inc.com
Pfanstiehl Inc.www.pfanstiehl.com
Schrödingerwww.schrodinger.com
Roquettewww.roquette.com
Quotient Scienceswww.quotientsciences.com
ShinEtsu Tylose GmbH & Co KGwww.se-pfmd.com
MedPharmwww.medpharm.com
Munit SAwww.munit.com
LTS Lohmannwww.ltslohmann.de
8
Who attends the DDF Summit?
By company type:
By seniority:
Common job functions:
R&D • Analytical Development • Pharmaceutical Development • Formulation Development • Technical Development • Device Development • Process Development • Drug Development • CMC • Human Factors • Innovation • Business Development
Scientist/Specialist 28.8% Manager 23.3% Director 20.2% Head 18.1% VP 6.1% C-Level 3.4%
1
6
2
5
8
4
9
10
7
3
By country: Top 10 countries:1 Germany 25.1%2 United Kingdom 14.9%3 United States 12.1%4 Switzerland 7.9%5 France 6.5%6 Denmark 5.4%7 Italy 3.9%8 Belgium 3.7%9 Spain 2.8%10 Austria 2.5%
Other countries represented:Netherlands South Korea Finland Japan Greece Ireland Czech Republic India Slovenia
Sweden Poland Portugal Northern Ireland
Norway Romania Taiwan China Hungary
Ghana Croatia Kuwait Macedonia Jordan
Pharmaceuticals Delivery / Formulation Services
Universities
58% 33% 9%
9
How to register
As an attendee:
If your company has a drug development pipeline and you work within a technical or R&D function then you can register as a delegate. Also open to scientists from academic or government organizations (not open to business development professionals).
Full rate: £395Early bird discounts available – contact Adrian Forde [email protected] to learn more!
Group discounts available! Book 5 passes to save 5%, 10 passes to save 10% and 15 to save 15%.
To register, please visit:
www.ddfsummit.com/book-now
As a commercial partner:
If you work for a technology, service or solution provider then you can only attend as a commercial partner.
As an official DDF Summit commercial partner, you can benefit from:
3 days of varied networking opportunities – providing you with ample time to meet and get to know the 300+ pharma development leaders in attendance
Speaking positions within targeted, highly technical streams – guaranteeing you a relevant and engaged audience
Exposure in the pre- and post-summit marketing campaigns
The chance for your team to get up to speed with the latest innovations and advances in drug delivery and formulation
There are a variety of options available to meet your business needs:
Business Development Package – a powerful injection of high quality leads into your pipeline
Thought Leadership Package – Intrigue, challenge and inspire with your innovative ideas and solutions
Bespoke Package – Tailored to suit your targets, goals and vision
Contact Alexandra for more information on the remaining opportunities.Alexandra Krcho, Account Director+44 (0) 203 874 9205 | [email protected]
10
Contact usIf you’d like to speak to us about anything at all then please use the details below:
General Enquiries:+44 (0) 207 738 [email protected]
Conference Content & Speaking:Ahmed Osman, Programme Director+ 44 (0) 203 874 [email protected]
Sponsorship Enquiries:Alexandra Krcho, Account Director+ 44 (0) 203 874 [email protected]
Follow us:#DDFSummit
Delegate Enquiries:Adrian Forde, Delegate Sales Director+ 44 (0) 203 874 [email protected]
Marketing & Media Enquiries:Elena Berrino, Conference Marketing Manager+44 (0) 203 874 [email protected]
11
11th Global
